Can a ginkgo pill protect the brain? new trial aims to find out
NCT ID NCT07287852
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug made from Ginkgo Biloba extract (Egb761) can lower a key Alzheimer's protein in the blood and improve thinking skills. Fifty adults with mild memory problems will take the drug twice daily for 6 months. The goal is to see if it can reduce brain disease activity and possibly slow decline.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hadassah medical Center
Jerusalem, 91120, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer light up Alzheimer's plaques in the living brain?
- Could Brain-Boosting exercises help older adults stay steady on their feet?
- Brain scans could unlock the hidden timeline of Alzheimer's
- Could breathing hydrogen protect the aging brain?
- App aims to empower older adults with memory challenges to master medication routines
- Could simple exercises slow cognitive decline? a new trial investigates.